Grant: Discovery Grants Program - Individual
University of Guelph
$45,000.00
Synthesis of oligosaccharides and glycoconjugates: search for novel anti-cancer vaccines and design of novel tether molecules to anchor bilayer lipid membranes to gold
EF 2011-12
Résumé
The basic expertise of our research group resides in synthetic carbohydrate chemistry. More recently, we have established additional expertise in molecular modeling of oligosaccharides using a combination of molecular mechanics methods and NMR measurements.
The main goal of our primary research program is to design through chemical synthesis safe anti-cancer vaccines based on Tumor Associated Carbohydrates (TACs) dimericLeX and LeALeX. Using these TACs as targets for the destruction of tumor cells is hampered by the fact that the LeA and LeX trisaccharides, which are fragments of these large structures, are expressed at the surface of many normal cells. Thus, when using anti-cancer drugs or vaccines that target dimericLeX and LeALeX, normal cells are at risk to be destroyed. In this context, our research aims at discovering analogues and fragments of these large hexasaccharides that no longer display the LeX or LeA trisaccharide but can still trigger an immune response that will recognize the TAC expressed on tumor cells. We have also established a second area of research that aims at designing and preparing pseudo-glycolipids that can be immobilized on gold via a thiol carried by the sugar residue. These molecules will be used to tether bilayer lipid membranes on a gold surface through the insertion of the lipid moiety into the first leaflet of the bilayer. Since the carbohydrate will then provide an aqueous layer between the anchored bilayer and the gold surface these constructs should permit the study of biological transmembrane events using modern state-of-the-art analytical techniques such as electrochemical scanning tunnelling microscopy (EC-STM) and atomic force spectroscopy (AFM).
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
238355-2011
Name nom
Auzanneau, FranceIsabelle
Department département
Chemistry
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2011
Award amount
45000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1504
Committee name en
Chemistry
Committee name fr
Chimie
Area of application code
504
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Human pharmaceuticals
Area of application fr
Produits pharmaceutiques administrables à l'homme
Research subject code
3702
Research subject group en
Organic chemistry
Research subject group fr
Chimie organique
Research subject en
Carbohydrates
Research subject fr
Glucides
Partie
1
Nb partie
5
Application title
Synthesis of oligosaccharides and glycoconjugates: search for novel anti-cancer vaccines and design of novel tether molecules to anchor bilayer lipid membranes to gold
Keyword
NSERC
Application summary
The basic expertise of our research group resides in synthetic carbohydrate chemistry. More recently, we have established additional expertise in molecular modeling of oligosaccharides using a combination of molecular mechanics methods and NMR measurements.
The main goal of our primary research program is to design through chemical synthesis safe anti-cancer vaccines based on Tumor Associated Carbohydrates (TACs) dimericLeX and LeALeX. Using these TACs as targets for the destruction of tumor cells is hampered by the fact that the LeA and LeX trisaccharides, which are fragments of these large structures, are expressed at the surface of many normal cells. Thus, when using anti-cancer drugs or vaccines that target dimericLeX and LeALeX, normal cells are at risk to be destroyed. In this context, our research aims at discovering analogues and fragments of these large hexasaccharides that no longer display the LeX or LeA trisaccharide but can still trigger an immune response that will recognize the TAC expressed on tumor cells. We have also established a second area of research that aims at designing and preparing pseudo-glycolipids that can be immobilized on gold via a thiol carried by the sugar residue. These molecules will be used to tether bilayer lipid membranes on a gold surface through the insertion of the lipid moiety into the first leaflet of the bilayer. Since the carbohydrate will then provide an aqueous layer between the anchored bilayer and the gold surface these constructs should permit the study of biological transmembrane events using modern state-of-the-art analytical techniques such as electrochemical scanning tunnelling microscopy (EC-STM) and atomic force spectroscopy (AFM).